Indian Journal of Urology Users online:8578  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

SYMPOSIUM

BPH and prostate cancer risk

Miah Saiful, Catto James

Year : 2014| Volume: 30| Issue : 2 | Page no: 214-218

   This article has been cited by
 
1 Predictive Value of Circulating Tumor Cells Detected by ISET® in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy
Laura Garrido Castillo, Arnaud Mejean, Philippe Vielh, Julien Anract, Alessandra Decina, Bertrand Nalpas, Naoual Benali-Furet, Isabelle Desitter, Patrizia Paterlini-Bréchot
Life. 2022; 12(2): 165
[Pubmed]  [Google Scholar] [DOI]
2 Alterations in fecal short chain fatty acids (SCFAs) and branched short-chain fatty acids (BCFAs) in men with benign prostatic hyperplasia (BPH) and metabolic syndrome (MetS)
Weronika Ratajczak, Arnold Mizerski, Aleksandra Ryl, Marcin Slojewski, Olimpia Sipak, Malgorzata Piasecka, Maria Laszczynska
Aging. 2021; 13(8): 10934
[Pubmed]  [Google Scholar] [DOI]
3 Differential gene expression of BCL-2, ZEB2-AS1 and BALR-2 in prostate cancer and benign prostatic hyperplasia
Maryam Ahani, Sayyed Mohammad Hossein Ghaderian, Mitra Mehr Azma, Koosha Kamali, Bahar Naghavi Gargari, Golnaz Bahramali, Reza Akbarzadeh
Andrologia. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Evaluation of circulating tumor cell clusters for pan-cancer noninvasive diagnostic triaging
Andrew Gaya, Timothy Crook, Nicholas Plowman, Anantbhushan Ranade, Sewanti Limaye, Amit Bhatt, Raymond Page, Revati Patil, Pradip Fulmali, Vineet Datta, Prashant Kumar, Darshana Patil, Dadasaheb Akolkar
Cancer Cytopathology. 2021; 129(3): 226
[Pubmed]  [Google Scholar] [DOI]
5 Mechanistic targets for BPH and prostate cancer–a review
Abhishek Shah, Aarti Abhishek Shah, Nandakumar K, Richard Lobo
Reviews on Environmental Health. 2021; 36(2): 261
[Pubmed]  [Google Scholar] [DOI]
6 A STUDY TO CORRELATE HISTOPATHOLOGY, SERUM PSA LEVEL AND IMMUNOHISTOCHEMICAL EXPRESSION OF ER & PR IN PROSTATIC GROWTH
Prashant Bhardwaj, Sumit Nandy, Keya Basu, Manjari Kumari, Dilip Karmakar
INDIAN JOURNAL OF APPLIED RESEARCH. 2021; : 66
[Pubmed]  [Google Scholar] [DOI]
7 Discovering pathways in benign prostate hyperplasia: A functional genomics pilot study
Zheling Chen, Minyao Ge
Experimental and Therapeutic Medicine. 2021; 21(3)
[Pubmed]  [Google Scholar] [DOI]
8 Whole-exome sequencing for high-risk primary prostatic extra-gastrointestinal stromal tumor: A case report
Li Lu, Hu Qu, De Wang, Bin Yao, Bo Ma, Jian Qiu, Zhong Wang, Dong Ren
Molecular and Clinical Oncology. 2021; 15(6)
[Pubmed]  [Google Scholar] [DOI]
9 The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
Natalie Silk, Jeremy Reich, Rahul Sinha, Shivansh Chawla, Kyla Geary, Dianzheng Zhang
Journal of Xenobiotics. 2021; 11(1): 16
[Pubmed]  [Google Scholar] [DOI]
10 Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure
Akhilesh Prajapati, Gaurav Chauhan, Harsh Shah, Sarita Gupta
Journal of Trace Elements in Medicine and Biology. 2020; 62: 126633
[Pubmed]  [Google Scholar] [DOI]
11 Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells
Balaji Chandrasekaran, Nisha R. Dahiya, Ashish Tyagi, Venkatesh Kolluru, Uttara Saran, Becca V. Baby, J. Christopher States, Ahmed Q. Haddad, Murali K. Ankem, Chendil Damodaran
Oncogenesis. 2020; 9(2)
[Pubmed]  [Google Scholar] [DOI]
12 Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options
Marlena Janiczek, Lukasz Szylberg, Paulina Antosik, Anna Kasperska, Andrzej Marszalek
Journal of Immunology Research. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
13 Light-controlled calcium signalling in prostate cancer and benign prostatic hyperplasia
Vipin Sharma, Rita Rana, Ruma Baksi, Swapnil P. Borse, Manish Nivsarkar
Future Journal of Pharmaceutical Sciences. 2020; 6(1)
[Pubmed]  [Google Scholar] [DOI]
14 Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis
Bo-Ram Jin, Hyo-Jin An
Aging. 2020; 12(3): 2142
[Pubmed]  [Google Scholar] [DOI]
15 Epidemiology, Staging and Management of Prostate Cancer
Adam Barsouk, Sandeep Anand Padala, Anusha Vakiti, Azeem Mohammed, Kalyan Saginala, Krishna Chaitanya Thandra, Prashanth Rawla, Alexander Barsouk
Medical Sciences. 2020; 8(3): 28
[Pubmed]  [Google Scholar] [DOI]
16 Zinc Deficiency in Men Over 50 and Its Implications in Prostate Disorders
Ann Katrin Sauer, Hector Vela, Guillermo Vela, Peter Stark, Eduardo Barrera-Juarez, Andreas M. Grabrucker
Frontiers in Oncology. 2020; 10
[Pubmed]  [Google Scholar] [DOI]
17 Anti-Proliferative Effects of Standardized Cornus officinalis on Benign Prostatic Epithelial Cells via the PCNA/E2F1-Dependent Cell Cycle Pathway
Bo-Ram Jin, Se-Yun Cheon, Hyo-Jung Kim, Myoung-Seok Kim, Kwang-Ho Lee, Hyo-Jin An
International Journal of Molecular Sciences. 2020; 21(24): 9567
[Pubmed]  [Google Scholar] [DOI]
18 Multiparametric MRI evaluation in benign prostatic hyperplasia – a true challenge in prostate cancer exclusion
Sandra O. Jurca, Gabriel Gluck, Ioana G. Lupescu
Oncolog-Hematolog.ro. 2019; 4(49): 23
[Pubmed]  [Google Scholar] [DOI]
19 Iodine Bonded with Milk Protein Inhibits Benign Prostatic Hyperplasia Development in Rats
Vladimir G. Bespalov, Valerii A. Alexandrov, Grigory V. Tochilnikov, Dmitrii ?. Lukin, Nadezhda T. Zhilinskaya, Alexandr L. Semenov, Irina N. Vasilyeva, Vladimir A. Romanov, Irina A. Tumanyan, Elena D. Ermakova, Elizaveta I. Kovalevskaya, Nadezhda V. Barakova, Denis A. Baranenko
Anti-Cancer Agents in Medicinal Chemistry. 2019; 19(13): 1627
[Pubmed]  [Google Scholar] [DOI]
20 Treatment options for benign prostate enlargement
Deidre Vlotman-Novinuk
Journal of Prescribing Practice. 2019; 1(3): 130
[Pubmed]  [Google Scholar] [DOI]
21 Long noncoding RNA DNM3OS promotes prostate stromal cells transformation via the miR-29a/29b/COL3A1 and miR-361/TGFß1 axes
Ruizhe Wang, Mengda Zhang, Zhenyu Ou, Wei He, Lingxiao Chen, Junjie Zhang, Yao He, Ran Xu, Shusuan Jiang, Lin Qi, Long Wang
Aging. 2019; 11(21): 9442
[Pubmed]  [Google Scholar] [DOI]
22 Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population
Mohammad Taheri, Farkhondeh Pouresmaeili, Mir Davood Omrani, Mohsen Habibi, Shaghayegh Sarrafzadeh, Rezvan Noroozi, Azadeh Rakhshan, Arezou Sayad, Soudeh Ghafouri-Fard
Biomarkers in Medicine. 2017; 11(5): 413
[Pubmed]  [Google Scholar] [DOI]

 

Read this article